scispace - formally typeset
M

Marco Bregni

Researcher at Vita-Salute San Raffaele University

Publications -  125
Citations -  9376

Marco Bregni is an academic researcher from Vita-Salute San Raffaele University. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 38, co-authored 125 publications receiving 8853 citations.

Papers
More filters
Journal ArticleDOI

Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells

TL;DR: Using a DNA probe that is specific for the complete gene (c-myc), different somatic cell hybrids possessing varying numbers of human chromosomes were analyzed by the Southern blotting technique and results indicate that the human c- myc gene is located on chromosome 8.
Journal ArticleDOI

Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation

TL;DR: The rapid haematological recovery made possible by this approach promises to increase the therapeutic index of high-dose chemoradiotherapy regimens and to widen their role as treatment for chemoradiosensitive tumours.
Journal ArticleDOI

Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients

TL;DR: The data presented in this article favor clinical use of the CD34/CD33 flow cytometry assay to guide harvesting of circulating hematopoietic progenitors for autologous transplantation and contribute to better understanding of the role played by circulating hepatopoiety progenitor cell subsets in marrow recovery after myeloablative cancer therapy.
Journal ArticleDOI

High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma.

TL;DR: High-dose sequential therapy is superior to standard-dose MACOP-B for patients with diffuse large-cell lymphoma of the B-cell type and overall survival at seven years is marginally significant.